Teva Pharmaceutical
TEVA
$1.79 (12.81%)
1D
1W
3M
1Y
5Y
ALL
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 8 hours ago • TEVA
Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesMarket Watch • 10 hours ago • TEVA
Teva Pharmaceutical's stock climbs as schizophrenia treatment shows promiseReuters • 12 hours ago • TEVA
Teva Pharm Q1 profit falls short of estimates, revenue gainsBusiness Wire • 1 day ago • TEVA
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial OutlookReuters • 1 day ago • TEVA
Teva and Medincell's schizophrenia drug meets main goal of late-stage studyCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.